Emerging Viruses in the Republic of Suriname: Retrospective and Prospective Study into Chikungunya Circulation and Suspicion of Human Hantavirus Infections, 2008–2012 and 2014

Goeijenbier, Marco; Aron, Georgina I.; Anfasa, Fatih; Lundkvist, Åke; Verner-Carlsson, Jenny; Reusken, Chantal; Martina, Benedict; Gorp, Eric C. M. Van; Resida, Lesley

doi:10.1089/vbz.2015.1798

Cited by 10 publications

(5 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, serological evidence of hantavirus infection has also been detected in Suriname (Armien et al, 2013;Figueiredo et al, 2014;Goeijenbier et al, 2015). One imported HFRS case has been reported in Ecuador (Demeester et al, 2010).…”

Section: American Countriesmentioning

confidence: 95%

Hantavirus infection: a global zoonotic challenge

et al. 2017

View full text Add to dashboard Cite

Hantaviruses are comprised of tri-segmented negative sense single-stranded RNA, and are members of the Bunyaviridae family. Hantaviruses are distributed worldwide and are important zoonotic pathogens that can have severe adverse effects in humans. They are naturally maintained in specific reservoir hosts without inducing symptomatic infection. In humans, however, hantaviruses often cause two acute febrile diseases, hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS). In this paper, we review the epidemiology and epizootiology of hantavirus infections worldwide.

show abstract

Section: American Countriesmentioning

confidence: 95%

Hantavirus infection: a global zoonotic challenge

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Jamaica has an all-age, national, active and passive surveillance system using medical practitioners, sentinel sites at primary healthcare centers, and major hospitals [76]. Suriname uses an all-age, national, active lab-based surveillance system (active since October 2014) [77]. Puerto Rico has several systems in place: an all-age, national passive physician-based surveillance system (active since the late 1960s); an all-age, national, passive and active system using forensic physician reports and post-mortem serum samples (active since 2010); and an all-age, national, active healthcare facility-based surveillance system (active since 2012) [78].…”

Section: Plos Neglected Tropical Diseasesmentioning

confidence: 99%

The global epidemiology of chikungunya from 1999 to 2020: A systematic literature review to inform the development and introduction of vaccines

Bettis

Jackson²,

Yoon

et al. 2022

PLoS Negl Trop Dis

View full text Add to dashboard Cite

Chikungunya fever is an acute febrile illness that is often associated with severe polyarthralgia in humans. The disease is caused by chikungunya virus (CHIKV), a mosquito-borne alphavirus. Since its reemergence in 2004, the virus has spread throughout the tropical world and several subtropical areas affecting millions of people to become a global public health issue. Given the significant disease burden, there is a need for medical countermeasures and several vaccine candidates are in clinical development. To characterize the global epidemiology of chikungunya and inform vaccine development, we undertook a systematic literature review in MEDLINE and additional public domain sources published up to June 13, 2020 and assessed epidemiological trends from 1999 to 2020. Observational studies addressing CHIKV epidemiology were included and studies not reporting primary data were excluded. Only descriptive analyses were conducted. Of 3,883 relevant sources identified, 371 were eligible for inclusion. 46% of the included studies were published after 2016. Ninety-seven outbreak reports from 45 countries and 50 seroprevalence studies from 31 countries were retrieved, including from Africa, Asia, Oceania, the Americas, and Europe. Several countries reported multiple outbreaks, but these were sporadic and unpredictable. Substantial gaps in epidemiological knowledge were identified, specifically granular data on disease incidence and age-specific infection rates. The retrieved studies revealed a diversity of methodologies and study designs, reflecting a lack of standardized procedures used to characterize this disease. Nevertheless, available epidemiological data emphasized the challenges to conduct vaccine efficacy trials due to disease unpredictability. A better understanding of chikungunya disease dynamics with appropriate granularity and better insights into the duration of long-term population immunity is critical to assist in the planning and success of vaccine development efforts pre and post licensure.

show abstract

“…Since its discovery in 1952, before the outbreak, there was no known virus circulation in the Caribbean or the Guiana Shield before the outbreak [ 11 ]. Two studies, in Suriname, the first in 1963 and, more recently, between 2008 and 2012, did not identify any CHIKV infection [ 12 , 13 ]. However, because of the epidemic and/or endemic risk, an epidemiological survey would have seemed indispensable to rule out the presence of CHIKV especially in the Amazon area where environmental conditions are optimal for Aedes proliferation.…”

Section: Local Epidemiologymentioning

confidence: 99%

Contribution of Research in the West Indies and Northeast Amazonia to Knowledge of the 2014–2015 Chikungunya Epidemic in the Americas

et al. 2021

View full text Add to dashboard Cite

Purpose of Review Although the chikungunya virus was discovered more than 60 years ago, it has only really been studied since the outbreak in La Reunion in 2005–2006. Ten years later, between 2014 and 2015, the chikungunya virus spread throughout the Americas, affecting millions of people. The objective of this review is to describe the contributions of research on chikungunya virus infection gained from epidemic in the West Indies and the Guiana Shield. Recent Findings Prevalence data were similar to those found in the Indian Ocean or Asia during epidemics. Clinically, there is now a better understanding of the typical, atypical, and severe forms. Several studies have insisted on the presence of neurological forms of chikungunya infection, such as encephalitis or Guillain–Barré syndrome. Cases of septic shock due to chikungunya virus as well as thrombotic thrombocytopenic purpura were described for the first time. Given the magnitude of the epidemic and the large number of people affected, this has led to a better description and new classifications of chikungunya virus infections in specific populations such as pregnant women, the elderly, and children. Several studies also described the behavior of populations faced with an emerging disease. Summary Current epidemiological data from tropical regions highlights the risk of spreading emerging diseases at higher latitudes, especially concerning arboviruses, since the vector Aedes albopictus is already established in many parts of northern countries. A better understanding of the disease and its epidemic dynamics will foster better management, the crucial importance of which was demonstrated during the COVID-19 epidemic.

show abstract

Emerging Viruses in the Republic of Suriname: Retrospective and Prospective Study into Chikungunya Circulation and Suspicion of Human Hantavirus Infections, 2008–2012 and 2014

Abstract: Here we report the presence of CHIKV in the republic of Suriname and the first serological indication of hantavirus infections in symptomatic patients.

Cited by 10 publications

References 29 publications

Hantavirus infection: a global zoonotic challenge

Hantavirus infection: a global zoonotic challenge

The global epidemiology of chikungunya from 1999 to 2020: A systematic literature review to inform the development and introduction of vaccines

Contribution of Research in the West Indies and Northeast Amazonia to Knowledge of the 2014–2015 Chikungunya Epidemic in the Americas

Contact Info

Product

Resources

About